Skip to main content
BEAT
NASDAQ Life Sciences

HeartBeam Details Commercialization, Clinical Advances in Q4 and Full-Year 2025 Report

Tom Rudovsky · Reported by FinanceWire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.37
Mkt Cap
$54.969M
52W Low
$0.54
52W High
$4
52W Position info
154% above low
Off High info
66% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

BEAT has more than doubled off its 52-week low of $0.54 on light trading volume (0.1× avg).

Summary

HeartBeam reported its Q4 and full-year 2025 results, concurrently detailing significant operational progress. This announcement provides crucial context following the 10-K filing yesterday, which disclosed a "going concern" warning. Key advancements include FDA 510(k) clearance for its 12-lead ECG synthesis software, the initiation of a limited market launch, and securing a first commercial partnership with ClearCardio. The company also began enrolling patients in its ALIGN-ACS pilot study and appointed a new Chief Commercial Officer. These commercial and clinical milestones are critical for the small medical technology company as it seeks to demonstrate a viable path to sustainability and address the auditor's concerns. Traders will closely monitor the execution of these commercialization efforts and the outcomes of clinical development.

At the time of this announcement, BEAT was trading at $1.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $55M. The 52-week trading range was $0.54 to $4.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: FinanceWire.


Price Chart

Share this article

Copied!

BEAT - Latest Insights

BEAT
Nov 02, 2026, 8:31 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.5402
Real-time Price: $0.3851 info
Change: -$0.1551 (-29%) info
Market Cap: $22.241M info
BEAT
Oct 26, 2026, 8:38 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.4061
Real-time Price: $0.3851 info
Change: -$0.021 (-5%) info
Market Cap: $22.241M info
BEAT
Oct 05, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $0.697014
Real-time Price: $0.3851 info
Change: -$0.311914 (-45%) info
Market Cap: $22.241M info
BEAT
Oct 05, 2026, 8:31 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $0.4154
Real-time Price: $0.3851 info
Change: -$0.0303 (-7%) info
Market Cap: $22.241M info
BEAT
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.370
Real-time Price: $0.3851 info
Change: +$0.0151 (+4%) info
Market Cap: $22.241M info